Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Curent Deferred Tax Liability (2016 - 2019)

Historic Curent Deferred Tax Liability for Assembly Biosciences (ASMB) over the last 5 years, with Q1 2019 value amounting to $3.3 million.

  • Assembly Biosciences' Curent Deferred Tax Liability rose 5226.13% to $3.3 million in Q1 2019 from the same period last year, while for Mar 2019 it was $3.3 million, marking a year-over-year increase of 5226.13%. This contributed to the annual value of $3.3 million for FY2018, which is 5224.72% up from last year.
  • According to the latest figures from Q1 2019, Assembly Biosciences' Curent Deferred Tax Liability is $3.3 million, which was up 5226.13% from $3.3 million recorded in Q4 2018.
  • Assembly Biosciences' Curent Deferred Tax Liability's 5-year high stood at $11.6 million during Q1 2015, with a 5-year trough of $2.1 million in Q3 2018.
  • Over the past 5 years, Assembly Biosciences' median Curent Deferred Tax Liability value was $11.1 million (recorded in 2017), while the average stood at $8.3 million.
  • Its Curent Deferred Tax Liability has fluctuated over the past 5 years, first crashed by 8113.5% in 2018, then soared by 5226.13% in 2019.
  • Quarter analysis of 5 years shows Assembly Biosciences' Curent Deferred Tax Liability stood at $11.6 million in 2015, then fell by 4.14% to $11.1 million in 2016, then crashed by 80.79% to $2.1 million in 2017, then skyrocketed by 52.25% to $3.3 million in 2018, then changed by 0.0% to $3.3 million in 2019.
  • Its last three reported values are $3.3 million in Q1 2019, $3.3 million for Q4 2018, and $2.1 million during Q3 2018.